Q1 2022 Holdings
Filed 2022-05-16 | 74 holdings | $300.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $32.4K | 507,374 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $36.2K | 1,094,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $40.6K | 1,239,000 | 0.0% |
| Merus NV | COM | N5749R100 | $50.2K | 1,900,000 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $52.1K | 6,871,642 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $62.9K | 700,000 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $64.7K | 1,714,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $66.2K | 1,303,700 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $69.0K | 6,448,359 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $72.8K | 3,498,636 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $79.9K | 2,669,132 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $88.9K | 3,484,264 | 0.0% |
| iTeos Therapeutics Inc(5E7) | COM | 46565G104 | $102.7K | 3,192,058 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $117.2K | 2,075,905 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | COM | 60468T105 | $164.4K | 2,000,000 | 0.1% |
| Cabaletta Bio Inc(CABA) | COM | 12674W109 | $1.1M | 540,000 | 0.4% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $5.3M | 1,188,405 | 1.8% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $5.6M | 2,014,858 | 1.9% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $11.2M | 1,074,082 | 3.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $28.3M | 2,200,000 | 9.4% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $30.6M | 1,263,930 | 10.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $45.2M | 1,432,200 | 15.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $77.3M | 2,100,000 | 25.7% |
| BeiGene Ltd(ONC) | SPONSORED ADR | 07725L102 | $94.3M | 500,000 | 31.4% |